California Nanotechnologies Corp. (TSXV:CNO)
Canada · Delayed Price · Currency is CAD 0.3100
+0.0150 (5.08%)
Aug 27, 2026, 2:33 PM EST
TSXV:CNO Income Statement
Financials in millions USD. Fiscal year is March - February.
Millions USD. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
| 2.99 | 2.79 | 6.22 | 3.34 | 1.38 | 1.08 | |
Revenue Growth | -42.42% | -55.20% | 86.51% | 141.51% | 27.78% | 36.11% |
Cost of Revenue | 1.5 | 1.29 | 1.64 | 1.01 | 0.39 | 0.32 |
Gross Profit | 1.49 | 1.5 | 4.59 | 2.33 | 0.99 | 0.76 |
Selling, General & Admin | 2.11 | 2.07 | 2.1 | 1.18 | 0.6 | 0.41 |
Research & Development | - | - | 0 | - | - | - |
Operating Expenses | 3.55 | 3.49 | 3.2 | 1.7 | 0.8 | 0.55 |
Operating Income | -2.06 | -1.99 | 1.38 | 0.64 | 0.19 | 0.21 |
Interest Expense | -0.12 | -0.12 | -0.19 | -0.11 | -0.11 | -0.08 |
Currency Exchange Gain (Loss) | -0.01 | -0 | -0 | 0 | -0 | 0 |
Other Non Operating Income (Expenses) | 0.3 | 0.27 | -1.19 | -0.15 | 0.01 | -0.01 |
EBT Excluding Unusual Items | -1.89 | -1.85 | -0 | 0.38 | 0.08 | 0.12 |
Gain (Loss) on Sale of Assets | - | - | 0.01 | - | - | - |
Other Unusual Items | 0.03 | - | - | - | - | 0.08 |
Pretax Income | -1.85 | -1.85 | 0.01 | 0.38 | 0.08 | 0.2 |
Income Tax Expense | 0 | 0 | 0.17 | - | 0 | - |
Net Income | -1.86 | -1.86 | -0.16 | 0.38 | 0.08 | 0.2 |
Net Income to Common | -1.86 | -1.86 | -0.16 | 0.38 | 0.08 | 0.2 |
Net Income Growth | - | - | - | 378.51% | -60.24% | - |
Shares Outstanding (Basic) | 46 | 46 | 45 | 35 | 32 | 32 |
Shares Outstanding (Diluted) | 46 | 46 | 45 | 39 | 33 | 32 |
Shares Change | 0.72% | 1.05% | 16.63% | 17.88% | 2.25% | 1.99% |
EPS (Basic) | -0.04 | -0.04 | -0.00 | 0.01 | 0.00 | 0.01 |
EPS (Diluted) | -0.04 | -0.04 | -0.00 | 0.01 | 0.00 | 0.01 |
EPS Growth | - | - | - | 311.01% | -61.73% | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Free Cash Flow | -1.02 | -0.43 | 0.8 | 0.09 | 0.54 | 0.14 |
Free Cash Flow Per Share | -0.02 | -0.01 | 0.02 | 0.00 | 0.02 | 0.00 |
Gross Margin | 50.00% | 53.69% | 73.66% | 69.88% | 71.68% | 70.03% |
Operating Margin | -68.87% | -71.51% | 22.20% | 19.03% | 13.69% | 19.42% |
Profit Margin | -62.18% | -66.60% | -2.54% | 11.44% | 5.77% | 18.55% |
Free Cash Flow Margin | -34.10% | -15.51% | 12.80% | 2.70% | 38.88% | 12.58% |
EBITDA | -1.72 | -1.66 | 1.59 | 0.75 | 0.3 | 0.32 |
EBITDA Margin | -57.61% | -59.57% | 25.61% | 22.56% | 21.99% | 29.84% |
D&A For EBITDA | 0.34 | 0.33 | 0.21 | 0.12 | 0.11 | 0.11 |
EBIT | -2.06 | -1.99 | 1.38 | 0.64 | 0.19 | 0.21 |
EBIT Margin | -68.87% | -71.51% | 22.20% | 19.03% | 13.69% | 19.42% |
Effective Tax Rate | - | - | 1598.94% | - | 4.83% | - |
Advertising Expenses | - | 0.14 | 0.11 | 0.1 | 0.04 | 0.04 |